baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

Argenx SE/ NL0010832176 /

3/31/2023 5:35:30 PM	Chg. -1.80	Volume	Bid5:35:30 PM	Ask5:35:30 PM	High	Low
340.80EUR	-0.53%	21,616 Turnover: 2.96 mill.	-Bid Size: -	-Ask Size: -	342.75	339.00

GlobeNewswire 3/28/2022 argenx announces closing of global offering

GlobeNewswire 3/24/2022 argenx raises $700 million in gross proceeds in a global offering

GlobeNewswire 3/22/2022 argenx announces launch of proposed global offering

GlobeNewswire 3/3/2022 argenx Reports Full Year 2021 Financial Results and Provides Fourth Quarter Business Update

GlobeNewswire 3/1/2022 Zai Lab Announces Financial Results and Corporate Updates for Twelve Months Ended December 31, 2021

GlobeNewswire 2/28/2022 argenx to Present at the 42nd Annual Cowen Health Care Conference

GlobeNewswire 2/24/2022 argenx to Report Full Year 2021 Financial Results and Fourth Quarter Business Update on March 3, 202...

GlobeNewswire 2/10/2022 argenx to Present at the 11th Annual SVB Leerink Global Healthcare Conference

GlobeNewswire 1/3/2022 argenx to Present at 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire 12/21/2021 OSE Immunotherapeutics Strengthens Leadership Team with the Appointment of Laurence de Schoulepnikof...

GlobeNewswire 12/18/2021 Zai Lab Partner argenx Announces U.S. Food and Drug Administration (FDA) Approval of VYVGART™ (efgar...

GlobeNewswire 11/15/2021 Zai Lab Announces First Patient Dosed in Greater China in Global Registrational Clinical Trial of Ef...

GlobeNewswire 11/10/2021 argenx to Present at Upcoming Investor Conferences

GlobeNewswire 11/9/2021 Zai Lab Announces Third Quarter 2021 Financial Results and Corporate Updates

GlobeNewswire 10/28/2021 argenx Reports Third Quarter 2021 Financial Results and Provides Business Update

GlobeNewswire 10/21/2021 argenx to Report Third Quarter 2021 Financial Results and Business Update on October 28, 2021

GlobeNewswire 10/8/2021 argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular ...

GlobeNewswire 9/3/2021 argenx to Present at Upcoming Investor Conferences

GlobeNewswire 8/25/2021 argenx Announces Validation of European Marketing Authorization Application for Efgartigimod in Gene...

GlobeNewswire 8/9/2021 Zai Lab Announces Second Quarter 2021 Financial Results and Corporate Updates

GlobeNewswire 8/4/2021 argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference

GlobeNewswire 7/29/2021 argenx Reports Half Year 2021 Financial Results and Provides Second Quarter Business Update

GlobeNewswire 7/22/2021 argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 202...

GlobeNewswire 7/14/2021 argenx to Host Virtual R&D Day on July 20, 2021

GlobeNewswire 7/1/2021 Healthtech Solutions, Inc. Bolsters Management and Board with Two New Appointments

Argenx SE/ NL0010832176 /

If you wish to receive reply to your feedback, please provide your email address.